Google Glass-Directed Monitoring and Control of Microfluidic Biosensors and Actuators. by Zhang, Yu Shrike et al.
UCLA
UCLA Previously Published Works
Title
Google Glass-Directed Monitoring and Control of Microfluidic Biosensors and Actuators.
Permalink
https://escholarship.org/uc/item/9cg5q4jd
Journal
Scientific reports, 6(1)
ISSN
2045-2322
Authors
Zhang, Yu Shrike
Busignani, Fabio
Ribas, João
et al.
Publication Date
2016-03-01
DOI
10.1038/srep22237
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
1Scientific RepoRts | 6:22237 | DOI: 10.1038/srep22237
www.nature.com/scientificreports
Google Glass-Directed Monitoring 
and Control of Microfluidic 
Biosensors and Actuators
Yu Shrike Zhang1,2,3, Fabio Busignani1,2,4,*, João Ribas1,2,5,6,*, Julio Aleman1,2,*, 
Talles Nascimento Rodrigues1,2,7, Seyed Ali Mousavi Shaegh1,2, Solange Massa1,2,8, 
Camilla Baj Rossi1,2,9, Irene Taurino1,2,9, Su-Ryon Shin1,2,3, Giovanni Calzone1,2,10, 
Givan Mark Amaratunga1,2,11, Douglas Leon Chambers1,2,12, Saman Jabari1,2,13, Yuxi Niu1,2,14, 
Vijayan Manoharan1,2, Mehmet Remzi Dokmeci1,2,3, Sandro Carrara9, Danilo Demarchi4 & 
Ali Khademhosseini1,2,3,15,16
Google Glass is a recently designed wearable device capable of displaying information in a smartphone-
like hands-free format by wireless communication. The Glass also provides convenient control over 
remote devices, primarily enabled by voice recognition commands. These unique features of the 
Google Glass make it useful for medical and biomedical applications where hands-free experiences are 
strongly preferred. Here, we report for the first time, an integral set of hardware, firmware, software, 
and Glassware that enabled wireless transmission of sensor data onto the Google Glass for on-demand 
data visualization and real-time analysis. Additionally, the platform allowed the user to control outputs 
entered through the Glass, therefore achieving bi-directional Glass-device interfacing. Using this 
versatile platform, we demonstrated its capability in monitoring physical and physiological parameters 
such as temperature, pH, and morphology of liver- and heart-on-chips. Furthermore, we showed the 
capability to remotely introduce pharmaceutical compounds into a microfluidic human primary liver 
bioreactor at desired time points while monitoring their effects through the Glass. We believe that 
such an innovative platform, along with its concept, has set up a premise in wearable monitoring and 
controlling technology for a wide variety of applications in biomedicine.
Accurate monitoring and control are key aspects in generating and collecting biological data, from morphol-
ogy to physiology and respective responses to stimuli. Advancements in the past decades have led to the devel-
opment of a variety of high-precision biosensors and actuators for unprecedented biomedical applications1–5. 
Particularly, the recent advancements in combining them with microfluidic devices have garnered tremendous 
attention due to their capability of low-volume analysis, high-throughput fluid handling, and miniaturization6–8. 
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For example, microfluidic bioreactors have been fabricated to mimic the human physiological system, termed as 
organs-on-a-chip platforms9–22. These platforms predict physiological responses with high accuracy, and typically 
encompass a set of finely designed microfluidic organoid modules interconnected together10,23, pneumatic-driven 
valves,2–5 and biosensing units24,25. However, they generally require frequent, on-demand monitoring and control, 
since the observation period can last from hours to weeks9,24,26.
The use of conventional desktop computers limits the user mobility and data accessibility, slowing down 
data-driven decision-making processes. This is especially problematic when monitoring over extended periods 
of time. Recent advances in mobile technologies such as smartphones and tablets27–38, and especially new weara-
ble devices such as bands and smart watches39–41, have paved an entirely new avenue for fulfilling these tasks in a 
much more flexible and remote manner, greatly reducing the labor effort and improving data accessibility. Among 
all, the Google Glass (Supplementary Fig. 1) accounts for one of the most promising smart devices concept, rely-
ing on a hands-free computing system with accurate voice control and imaging capabilities to enable on-the-fly 
human-machine interactions. The built-in wireless functions (Wi-Fi and Bluetooth) potentiate mobility by con-
necting directly (Wi-Fi) or indirectly (via Bluetooth-paired smartphone/tablet). These advantages have proven 
the Google Glass useful for a range of biological/biomedical applications including plant disease detection42, 
remote surgical communications and image-guided surgery43, diabetes management44, and point-of-care 
diagnostics45.
Here, we demonstrate for the first time a Google Glass-directed monitoring and control of microfluidic bio-
sensors and actuators using a set of integrated sensors, hardware, software, and Glassware. Using a liver- and 
heart-on-a-chip systems as a model platform, we demonstrated seamless transmission of biosensor data onto the 
Google Glass for on-demand visualization and analysis of i) temperature and pH values, ii) microscopic obser-
vations (e.g. morphology of liver/cardiac organoids and video of beating cardiac organoids), and iii) on-Glass 
analysis (e.g. beating rate). Moreover, we showed our capability to selectively actuate microfluidic pneumatic 
valves and reservoirs to study the effects of pharmaceutical compounds on liver organoids in a primary human 
liver-on-a-chip platform. The Glass might be of particular importance in cases where the experimental condi-
tions threaten human life, as when researchers work with highly contagious bacteria and virus or radioactivity. 
We believe that our Google Glass-based platform for monitoring and control will find widespread applications 
in biomedicine and may be further expanded to healthcare and environmental analysis where telemetry, remote 
control, and on-demand human-machine interactions are required in a safer manner.
Results and Discussion
Hardware, software, and Glassware for data transmission. Wearable devices allow us to interact in 
new ways with data and enable us to take fast decision-making actions. When designing such wearable techno-
logical solutions it is ideal that the interaction is a two-way process – one should be able to see new data and take 
appropriate action through the wearable that translates into tangible changes in the system. With this aim, we 
designed a Glassware solution to monitor and control microfluidic and organs-on-a-chip systems, aided by a set 
of custom-developed hardware and software.
The Google Glass communicates with the sensors via the Google App Engine (Fig. 1A). Data is stored in the 
Google Cloud, and the Glass periodically checks for new sensor data, such as the latest video of cardiomyocyte 
beating. A custom-built printed circuit board (PCB) shield (Supplementary Fig. 2) interfaces the sensors and 
the actuators (electrovalves) to an embedded Linux board (BeagleBone Black). This board was chosen for its 
low-cost, powerful processor, and high number (in total 92) of pins that allow the connection of multiple sen-
sors and controllers. Furthermore, the board, programmed using C+ + , uses the Open Source Computer Vision 
(OpenCV) library to plot beating patterns from cardiomyocyte videos, based on our previously published work 
on the pixel-shift method46,47. To transmit data from the Beagle Bone to the Google App Engine we used the cURL 
library with simple http post and http get operations.
The voice control command (“ok glass”) gives the users access to the designed Glassware custom card 
(Measurement, Fig. 1B). Once the Glassware is launched, a set of Live Cards can be accessed via swiping, giving 
the user access to view the pH and temperature values, a video of the cells, and a plot of the beating patterns 
(Fig. 1B, bottom panel). Additionally, the user has access to a Live Card that actuates electrovalves, which can con-
trol the flow direction and addition of drugs in the microfluidic system. For the electrovalves a driver circuit was 
specifically designed to meet their voltage and current needs, and was controlled via digital output signals from the 
BeagleBone board. We have also designed custom circuits for temperature and pH sensors (Supplementary Fig. 2) 
in order to amplify the signals and reduce the noise of the sensors.
Overall, the sensor data is stored in the Google App Engine, and retrieved whenever the Glassware appli-
cation is started and then refreshed periodically. Video files are also stored locally in a computer, so that data 
from any different time-point can be retrieved when needed. To actuate the different electrovalves, the Google 
Glass changes the status (on/off) of each one of the electrovalves in the Google App Engine, and the Linux board 
periodically checks for these status and makes concordant changes. Together, the developed platform allows the 
Glassware to update the user on data coming from the sensors and enable the user to take action through the 
control of electrovalves.
Physical sensing units for real-time temperature and pH monitoring. Microfabricated sensors were 
obtained using our published miniaturized approach48. Figure 2A shows a schematic of the sensor array meas-
uring 2.2 × 15 mm2, which hosts five biosensor platforms, a temperature sensor, and a pH electrode. The entire 
sensor array was fabricated from biocompatible materials and integrated with a complementary metal-oxide 
semiconductor (CMOS) chip for measurements. As a proof of principle, we chose to only probe the temperature 
and pH responses of the sensor array to characterize the physical microenvironment of our system. The right 
panel in Fig. 2A indicates a magnified view of the temperature and pH sensing units of the sensor array, where the 
www.nature.com/scientificreports/
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temperature sensor consisted of a platinum (Pt) zigzagging path of 0.02 × 16 mm2 for each turn. Pt was chosen 
due to its linearity within the physiological temperature range and higher resistivity, which efficiently confined the 
size of the sensor to a small footprint49. The pH sensor consisted of a 250-μm2 metal pad that was electrodeposited 
with a thin film of iridium oxide (IrOx). Changes in the pH of the surrounding medium were measured by open 
circuit potential of the electrode50,51. To achieve continual monitoring of the microenvironment, the sensor array 
was enclosed in a microfluidic device, with a 3 × 15 × 0.2 mm3 chamber placed directly on top of the sensing 
units, resulting in a small working volume of < 10 μL (Fig. 2B). Calibration curves for temperature and pH utiliz-
ing the enclosed microfluidic device show a linear correlation, and a sensitivity of 3.6 Ω °C−1 and − 67.9 mV pH−1 
at the flow rate of 200 μm h−1 (Fig. 2C,D).
We further integrated a miniature microscope that we have recently developed for image and video acquisi-
tion46,47,52. The microscope was fabricated from a webcam and off-the-shelf components46. Figure 2E,F show a 
schematic and a photograph of the mini-microscope integrated with a microfluidic bioreactor, respectively. The 
imaging unit was constructed by flipping the webcam lens and re-attaching it to the CMOS sensor in order to 
achieve magnification rather than the de-magnifying mechanism that a webcam requires46. This imaging unit was 
fitted on a set of poly(methyl methacrylate) (PMMA) frames sandwiched by screws/bolts and the microfluidic 
bioreactor placed above the sensor. A mini-microscope image of HepG2 cells in a liver bioreactor is shown in 
Fig. 2G, where individual cells could be observed, highlighting the high resolution of the mini-microscope.
In order to transmit the data to the Google App Engine a custom PCB board was designed to accommo-
date the BealgeBone Black for connection with the pH and temperature sensors as well as the mini-microscope 
Figure 1. Principle of Google Glass-directed monitoring of sensor data and control of actuators.  
(A) Scheme of the interactions between the Google Glass and the hardware and software components.  
(B) Diagrams showing the operation procedure on the Google Glass. Upper panel shows the home screen, 
which upon voice control (“ok glass”) or tapping brings out the custom Card Measurement and enters the 
application; lower panel shows a series of Live Cards can then be reached by swiping. Tapping on each Card 
shows the corresponding measurement data, beating analysis, or the control card for the electrovalves.
www.nature.com/scientificreports/
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(Fig. 2H,I). The micro-computing unit then records the data and image/videos and constantly transmits them 
remotely to the Cloud for the Glass to fetch and display.
Remote monitoring of liver- and heart-on-a-chip platforms. To test the capability of our Google Glass 
system for visualizing sensor data we monitored liver- and heart-on-a-chip platforms. The multi-layer microfluidic 
bioreactor was fabricated following our recently published protocol (Fig. 3A,B)10, where the bioreactor chambers 
were made of polydimethylsiloxane (PDMS). The bioreactor was designed to be re-usable and re-sealable, pro-
viding easy access to seeding cells or placing organoids inside the chamber. To construct the liver bioreactor we 
seeded HepG2 cells in the bottom chamber at a density of approximately 1000 cells mm−2. The mini-microscope 
was fitted at the bottom of the culture chamber for continuous monitoring of cell behavior. The images acquired 
from the mini-microscope were successfully transmitted to the Google Glass wirelessly and visualized in the View 
Image Live Card (Fig. 3C). The mini-microscope images can be acquired at a pre-set time interval and saved 
locally on the computer. Importantly, the latest acquired image is wirelessly transmitted to the Google Glass, where 
Figure 2. Biosensors and hardware for data recording, transmission, and command control.  
(A) Schematic showing the microfabricated biosensor chip containing temperature sensor, electrochemical pH 
sensor, and immunosensor array. (B) A microfluidic device hosting the biosensor chip for continuous sensing. 
(C,D) Calibration curves for temperature and pH sensors, respectively. (E,F) Schematic and photograph 
showing the mini-microscope. (G) Resolution testing of the mini-microscope. (H) Schematic showing the 
design of the electronic circuit for temperature/pH reading from the sensor and controlling electrovalves. (I) 
Photograph showing the assembled platform of the electronic circuit (top) and a BeagleBone board (bottom) 
for simultaneous reading of the sensor data, communication with the mini-microscope, and control over 
electrovalves.
www.nature.com/scientificreports/
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it then refreshes the Live Card for visualization. This feature enables the user to remotely access the microscopic 
images of the organoids in the bioreactors and monitor their morphological changes as a function of time.
However, in many cases, static images cannot be used to follow and measure fast dynamic cellular behaviors. 
We next demonstrated the capability of the Google Glass to simultaneously visualize and analyze mini-microscope 
videos using a simplified heart-on-a-chip platform. Heart-on-a-chip provides a versatile approach for studying 
the biology, physiology, as well as screening pharmaceutical compounds possessing cardiotoxicity26,53,54. The 
heart-on-a-chip platform was constructed by seeding rat neonatal cardiomyocytes on a piece of glass coated with 
a thin layer of 5 wt.% gelatin methacryloyl (GelMA) and 1 mg mL−1 carbon nanotubes (CNTs), followed by place-
ment of the construct in the chamber of a cardiac bioreactor (Fig. 3D). CNTs were embedded into the GelMA to 
promote the intercellular connections among the cardiomyocytes, therefore improving the functionality of the 
fabricated cardiac organoids55,56. Figure 3E is the View Image Live Card showing a mini-microscope image of the 
cardiomyocytes in the cardiac bioreactor transmitted to the Google Glass, indicating the formation of a confluent 
layer of cardiomyocytes on the GelMA/CNTs substrate.
Neonatal cardiomyocytes beat synchronously, but the beating frequency and pattern can be disturbed eas-
ily by administration of drugs/toxins or by changing the surrounding microenvironment (e.g. temperature). 
We therefore performed two sets of experiments to perturb the regular beating of the cardiac organoid in the 
heart-on-a-chip device. We first opened the incubator door for 10 min to allow the temperature to drop from 
37 °C to 27 °C, and then closed it back. The temperature sensor detected the drop in real-time (Fig. 3F), and the 
data was transmitted via the integrated system to the Google Glass and visualized in the View Temperature Live 
Card. The temperature data was consistent with that collected by a commercial sensor directly connected with a 
Figure 3. Real-time monitoring of organoid behaviors in an integrated liver-and-heart-on-a-chip platform 
on Google Glass. (A,B) Schematic and photograph showing the resealable microfluidic bioreactor. The mini-
microscopes were fitted at the bottom of the bioreactors while the biosensor unit was placed downstream of the 
bioreactors. (C) Google Glass view obtained from the mini-microscope fitted underneath the liver bioreactor 
showing the morphology of HepG2 cells. (D) Schematics showing the fabrication process of a GelMA substrate 
for constructing the cardiac tissue. The cardiac tissue was then transferred into the cardiac bioreactor.  
(E) Google Glass view obtained from the mini-microscope fitted underneath the cardiac bioreactor showing 
the morphology of rat cardiomyocytes. (F) Temperature sensing data visualized on the Google Glass, where the 
door of the incubator was opened for 10 min and then closed. (G) The same data was recorded on a LabVIEW 
program, indicating the same trend and accuracy of the data transmitted onto the Google Glass. (H–J) Beating 
analysis on the Google Glass of the cardiomyocytes under different conditions: (H) 23 °C for 10 min; (I) 23 °C 
for 30 min; and (J) 37 °C post treatment of DOX for 1 h.
www.nature.com/scientificreports/
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National Instruments data acquisition (NI-DAQ) card and LabVIEW (Fig. 3G), highlighting the accuracy and 
time responsiveness of the sensor data transmitted to the Google Glass. The beating of the cardiac organoid was 
monitored during the external manipulation of the temperature, recorded using the mini-microscope and the 
video wirelessly transmitted to the Google Glass (Supplementary Movie 1). When the heart-on-a-chip tempera-
ture decreased to 23 °C, even for only 10 min, the cardiomyocytes showed an irregular and reduced beating rate, 
which was analyzed and plotted on the Google Glass in the View Beating Live Card (Fig. 3H). Furthermore, 
when the cardiac bioreactor was completely removed from the incubator and cooled to room temperature for 
over 30 min, the cardiomyocytes completely ceased beating (Supplementary Movies 2 and Fig. 3I). Alternative to 
changing environmental conditions, the beating of the cardiac organoid was also tested by addition of cardiotoxic 
drugs. We infused the heart-on-a-chip with 50 μM of doxorubicin (DOX) for 1 h at 37 °C and monitored the beat-
ing. DOX, an anti-cancer drug with adverse side effects on cardiac tissues, was shown to induce acute arrhythmia 
of the cardiac organoid upon treatment at high doses (Supplementary Movie 3 and Fig. 3J)26,47,57,58.
The integrated BeagleBone board and software/Glassware sets allowed the data from the microfabricated sen-
sor, as well as still images and videos recorded by the mini-microscope, to be visualized and transmitted wirelessly 
to the Google Glass. The sensing capabilities of our system was enhanced with real-time analysis and concomitant 
visualization in the Google Glass. Importantly, the data were simultaneously recorded locally (on the computer 
where the BeagleBone board was connected), facilitating on-demand retrieval of the data at any time. In addition 
to organoids in bioreactors, a range of other static images or dynamic videos such as micropatterns and micro-
fluidic droplet generation could also be remotely monitored in real-time using the Google Glass (Supplementary 
Fig. 4 and Movie 4).
Remote control of actuators using Google Glass. Actuators play a pivotal role in microdevices, 
functioning as gating mechanisms for controlling a variety of devices based on electricity and mechanics59,60. 
For example, electrovalves are a category of electrically actuated valves that allow for opening and closure of 
pressure-driven valves that can be used to conveniently manipulate liquid flows inside a microfluidic device. 
Here we have developed a remote control platform where the BeagleBone board reads the wirelessly transmitted 
Google Glass commands and responds to actuate the electrovalves (Fig. 1A). The Glassware application has a 
set of Live Cards that allow turning on and off each electrovalve switch upon command (Fig. 4A). Selection of 
the “Drive Electrovalves” Card enables a list of eight valves in the screen of the Glass; upon swiping of the touch 
pad eight Live Cards will be sequentially shown, each of which can be individually triggered. To visually show 
the working concept, we prepared an array of eight LEDs connected to the outputs on the BeagleBone board 
(Fig. 2H,I). As shown in Fig. 4B–E, when the switches were selectively activated on the Google Glass the cor-
responding LEDs could be turned on and off. The capabilities to sequentially activate and deactivate LEDs and 
random manipulation are further shown in Supplementary Movies 5 and 6.
We subsequently constructed a microfluidic bioreactor consisting of an elliptical chamber, one central inlet for 
medium circulation, and two side inlets with corresponding pressure-driven pneumatic valves, which together 
with linked pressure-driven reservoirs (both activated by electrovalves), accomplish the injection of target agents 
(Fig. 4F). We then first demonstrated the capability to remotely actuate the valves with the commands wirelessly 
transmitted from the Google Glass to the BeagleBone board. As shown in Fig. 4G–K and Supplementary Movie 7, 
we initially injected medium in the central inlet, with both side channels closed by the valves (Fig. 4G). To drive 
blue dye from the reservoir to the bioreactor chamber we sequentially opened the channel by deactivating Valve 
1 and pressurized the blue dye reservoir by activating Valve 2 (Fig. 4H). Reversing these actions and performing 
the same Google Glass commands on Valves 3 and 4 drove yellow dye to infuse the bioreactor chamber (Fig. 4J). 
Finally, the valves were reset to the initial configuration, restoring the circulation of the medium through the 
central inlet (Fig. 4K).
Additionally, a mini-microscope was fitted at the bottom of the bioreactor for real-time monitoring, and con-
nected to the BeagleBone board. The insets in Fig. 4F–J, show the change in color of the liquid pumped into 
the bioreactor chamber, monitored by the mini-microscope in real-time. The dynamic process of synchronized 
mini-microscope recording, the activation of the valves, and injection of reagents into the bioreactor, together 
with the commands on the Google Glass can be observed in Supplementary Movie 7.
Simultaneous remote control and monitoring of liver-on-a-chip for drug testing. The main pur-
pose of the liver is to provide detoxification of various metabolites, protein/enzyme synthesis, and the production 
of bile necessary for digestion of food, rendering hepatotoxicity studies an important target for multiple fields. 
Here we introduced human primary hepatocytes into the chamber of the microfluidic bioreactor to construct a 
liver-on-a-chip platform. Liver spheroids of approximately 200 μm were first formed using a non-adherent microw-
ell array61, which were then retrieved, suspended in GelMA, and crosslinked to the bottom of the bioreactor cham-
ber. Prior to the experiment, 15 mM acetaminophen (APAP), a hepatotoxic drug, was added to the reservoir of one 
of the side channels. The liver bioreactor was initially perfused with hepatocyte culture medium from the central 
inlet in the first 24 h with the side channels closed (Fig. 5A,B). At 24 h we used the Google Glass to inject APAP 
for 1 min. Commands were sent from the Glass deactivating the valve and activating the pressure to inject APAP 
(Fig. 5C,D). The channel was then closed to stop the APAP injection and restore the regular perfusion with the 
hepatocyte growth medium (Fig. 5E,F). The mini-microscope fitted at the bottom of the bioreactor monitored the 
morphology of the liver spheroids, transmitting the data to the Google Glass for real-time, in situ monitoring of 
drug treatment effect. Without any drug, the liver organoid remained healthy and tightly agglomerated (Fig. 5G,H). 
In comparison, 12 h post injection of 15 mM APAP, the liver spheroid micrographs transmitted through the 
mini-microscope to the Google Glass showed swollen cellular structures (Fig. 5I), clearly indicating signs of a toxic 
response to APAP treatment. The decreased liver functionality was further confirmed by off-chip viability assay 
www.nature.com/scientificreports/
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and analysis of damage biomarker glutathione S-transferase α (GST-α, Fig. 5J–L), well correlating to the observed 
hepatotoxicity with the Google Glass-directed drug administration and organoid monitoring.
In this particular demonstration we highlight that the entire process, including the operation of the 
valves, injection of the drug, restoration of the main perfusion, and monitoring the morphology with the 
mini-microscope was solely controlled by the Google Glass without direct manipulation of the liver-on-a-chip 
device or the valves system. Such seamless interface allows for remote actuation of microfluidic devices and 
easy access of sensed data, potentially enabling long-term communication and control between humans and 
microdevices.
Conclusions
For the first time we have developed a set of hardware, firmware, and Glassware that enabled wireless transmission 
of sensor data onto the Google Glass for on-demand data visualization and real-time analysis. We have further 
engineered the hardware and software to allow the control of electrical outputs from commands entered by the 
Glass. We demonstrated the capability of the platform to monitor physical and physiological parameters such as 
Figure 4. Controlling electrovalves and microfluidic actuators using Google Glass. (A) Diagrams showing 
the control of the electrovalves on the Google Glass. (B–E) Demonstration of control over the blinking of LEDs 
from the Glass. (E) A microfluidic bioreactor with built-in valves and inlets for drug testing. A mini-microscope 
was fitted at the bottom of the bioreactor for real-time analysis. (F) Schematic of the microfluidic bioreactor for 
evaluating the Google Glass-directed electrovalve controllers. (F–K) Sequential activation of Valve 1 and Valve 2 
from the Glass, as indicated by alternation of dyes injected from the inlet, Agent 1 channel, and Agent 2 channel. 
Insets show images taken by the mini-microscope at the bottom of the bioreactor chamber clearly indicating 
matching color changes in the flow.
www.nature.com/scientificreports/
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temperature, pH, and microscopic morphological images and videos, of an integrated liver-and-heart-on-a-chip. 
The Glass also achieved beating analysis of the cardiac organoids. We then proved that the pneumatic electro-
valves could be remotely activated by the Glass to introduce pharmaceutical compounds into the microfluidic 
liver bioreactor at desired time points, with their effects being transmitted to the Glass for continuous real-time 
monitoring.
We believe that such an innovative platform is a premise in wearable sensing and controlling technology for 
applications in biomedicine, surgery and general laboratory. The Glass might be of particular importance in 
Figure 5. Remote activation of electrovalves using the Google Glass for drug testing on the liver-on-a-chip 
platform fabricated from human primary hepatocyte spheroids. (A,B) All valves were off to allow regular 
culture of the liver organoids. (C,D) At 24 h post culture, Valves 1/2 were activated from the Glass and 15 mM 
APAP was injected into the circulation for 1 min. (E,F) Valves 1/2 were then deactivated and the culture was 
maintained for another 12 h. (G–I) Mini-microscopic image clearly showed swelling, sign of apoptosis of the 
liver organoid post APAP treatment. (J,K) Live/dead assay of the liver organoids (J) with and (K) without APAP 
treatment, indicating increased cell death when the cells were incubated with APAP. (L) Levels of the liver 
damage biomarker GST-α measured by ELISA, showing the same trend of cell death when treated with APAP.
www.nature.com/scientificreports/
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cases where the experimental conditions threaten human life, as when researchers work with highly contagious 
bacteria and virus or radioactivity.
Methods
Microfabricated temperature and temperature sensors. The passive chip was microfabricated with a 
two-mask process flow. Silicon wafers with a layer of native oxide 500 nm in thickness were used as the substrate. 
The metallization of the wafers was achieved by first evaporation of 10 nm of titanium (Ti) as the adhesive layer, 
followed by 100 nm of Pt on top of Ti. Passivation of the metal was performed via atomic layer deposition of Al2O3 
of 20 nm in thickness62. The fabrication process is shown Supplementary Fig. 2. The pH sensor was functionalized 
by electrodeposition of IrOx onto the microelectrode, which was carried out by applying a constant current den-
sity of 0.15 mA cm-2 for 80 min in a solution of IrOx63. The pH was measured by reading the open circuit potential 
produced by the electrodes using a potentiostat (CHI684, CH instruments) and an external Ag/AgCl reference 
electrode (ET072-1, eEAQ). Temperature sensing was achieved by reading the sensor resistance using a precision 
source meter (B2901A, Agilent).
Software and Glassware. The Google Glass Explorer Edition was programmed using the Glass 
Development Kit in Java. The embedded Linux board BeagleBone Black was programmed in C+ + and bash 
command. OpenCV was used to calculate the beating rate of cardiomyocytes and cURL library was used to per-
form http post and get operations to the Google App Engine. The cloud-based Google App Engine, programmed 
in Python, and local video storing was done using the Qt framework.
Design of printed circuit board (PCB). A custom made PCB was designed using the National Instruments 
Circuit Design Suite, to accommodate the pH/temperature multisensor and the electrovalves driver and 
modified to attach the headers of the BeagleBone Black (Fig. S3). A conditioning circuit for both pH and temper-
ature sensors was designed to provide noise filtering with a low-pass filter. Additionally, the pH circuit performed 
a signal level shift, due to the fact that the pH sensor signals are bipolar. To drive the electrovalves (normally open, 
MH1-A-24VDC-N-HC-8V-PR-K01-QM-AP-BP-CX-DX, Festo), a specific circuit was designed with a low-side 
switch metal-oxide semiconductor (MOS). A DC-DC converter circuit was designed to provide compatibility 
with both 24 V and 12 V solenoid valves, and a relay circuit (voltage supply switch) provided the switch between 
these. Circuit designs followed the guidelines for reduced electromagnetic interference.
Mini-microscope. A commercial Logitech C160 webcam was dissembled to retrieve the complementary 
metal-oxide semiconductor (CMOS) sensor. We then inverted the lens to achieve magnification and convert the 
webcam into the mini-microscope52. The base structure of the mini-microscope was fabricated from a PMMA 
sheet by laser cutting (VLS 2.30 Desktop Laser System, Universal Laser Systems), following our recently published 
protocol46.
Liver- and heart-on-chips. Re-usable and re-sealable microfluidic bioreactors based on polydimethyl-
siloxane (PDMS, Dow Corning Sylgard 184, Ellsworth) were fabricated by modifying our recently developed 
protocol10. Specifically, the bioreactors had a double-layer configuration with the inlet and organoid chamber at 
the bottom and outlet on the top layer. The two PDMS layers could be disassembled for seeding the organoid, 
following which sealing were achieved by clamping the pieces using a pair of PMMA structures tightened by sets 
of screws/bolts.
HepG2/C3A human hepatocellular carcinoma cells (HB-8065, ATCC) were seeded onto the bottom of the 
bioreactors at a density of 2000 cells mm−2. Cultures of the organoids were maintained at a constant flow rate of 
200 μL h−1 in a Dulbecco’s Modified Eagle’s Medium (DMEM, Life Technologies) supplemented with 10 vol.% 
fetal bovine serum (FBS, Life Technologies) and 1 vol.% penicillin-streptomycin (P/S, Life Technologies). Primary 
human hepatocytes (HUCPI6, Triangle Research Labs, Research Triangle Park, NC) were seeded in a PDMS 
model containing arrays of 200-μm wells. To maintain the high cell viability, the hepatocyte growth media 
(Lonza) was replaced every 48 h. At Day 5 the spheroids were harvested and mixed with an aqueous solution 
containing 10 w/v% GelMA and 0.5 w/v% photo initiator Irgacure 2959 (Ciba, Hawthorne, NY). GelMA droplets 
with approximately 1 mm in size were bioprinted in the bioreactor chamber using a NovoGen MMX bioprinter 
(Organovo, San Diego, CA). After 17 s of UV exposure at 850 mW at a distance of 8.5 cm, the GelMA dots were 
successfully crosslinked to the bottom of the bioreactor10. When necessary, APAP was introduced into the biore-
actor at a concentration of 15 mM.
Cardiac bioreactors were constructed from neonatal rat cardiomyocytes, which were isolated from 
Sprague-Dawley rats of 2 days old following our established protocol approved by the Institutional Animal Care 
and Use Committee64. The cardiomyocytes were then seeded onto GelMA hydrogel mats (6 × 6 mm2) containing 
1 mg mL−1 CNTs at a number of 5 × 105 cells56. The GelMA-CNT mats seeded with cardiomyocytes were initially 
cultured in DMEM supplemented with 10 vol.% FBS, 1 vol.% P/S, and 1 vol.% L-glutamine (Life Technologies) 
for 3 days until consistent beating of the cells was observed. The constructs were subsequently transferred to the 
chambers of the bioreactors and perfusion-cultured at a flow rate of 200 μL h−1.
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